دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 4,800,000 تومان- قیمت ویژه : 2,400,000تومان
Breaking the cycle: time to invest in IBS
doi : 10.1016/S2468-1253(25)00130-X
Volume 10, Issue 6, June 2025, Page 491
U-ACTIVATE long-term efficacy and safety outcomes for upadacitinib in ulcerative colitis
Expanding the menu of dietary therapies in irritable bowel syndrome
The urgent need for implementation science to achieve hepatitis C elimination
Retraction and republication—Endoscopic ultrasonography-guided gastroenterostomy versus uncovered duodenal metal stenting for unresectable malignant gastric outlet obstruction (DRA-GOO): a multicentre randomised controlled trial
Inclusion of patients with isolated ulcerative proctitis in clinical trials
The pitfalls and promises of scoping reviews in gastroenterology literature
The pitfalls and promises of scoping reviews in gastroenterology literature – Authors’ reply
Long-term efficacy and safety of upadacitinib in patients with moderately to severely active ulcerative colitis: an interim analysis of the phase 3 U-ACTIVATE long-term extension study
Efficacy of dietary interventions in irritable bowel syndrome: a systematic review and network meta-analysis
Efficacy of gut–brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysis
Appendicectomy plus standard medical therapy versus standard medical therapy alone for maintenance of remission in ulcerative colitis (ACCURE): a pragmatic, open-label, international, randomised trial
Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trial
Endoscopic ultrasonography-guided gastroenterostomy versus uncovered duodenal metal stenting for unresectable malignant gastric outlet obstruction (DRA-GOO): a multicentre randomised controlled trial
The intestinal barrier: a pivotal role in health, inflammation, and cancer
Prevention and interception trials in inflammatory bowel disease: an international taskforce assessment on clinical trial design
